Previous 10 | Next 10 |
Specialty diagnostics company Precipio shares surge ([[PRPO]] +21.4%) after announcing the launch of its COVID-19 rapid antibody test (20 minute), which tests for both IgG & IgM antibodies, on Amazon.com's ([[AMZN]] -0.4%) platform.The antibody test, which is manufactured in the...
NEW HAVEN, Conn., May 03, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced that it has successfully launched its COVID-19 rapid antibody test (20 minute) which tests for both IgG & IgM antibodies, on Amazon.com's business p...
NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced that currently, the contracted annualized revenues from signed customers for its HemeScreen POL (Physician Office Laboratory) testing system exceed $7...
Gainers: Takung Art (TKAT) +33%.Teradata (TDC) +29%.Renalytix AI (RNLX) +24%.Qualtrics International (XM) +24%.Galectin Therapeutics (GALT) +23%.Kaleido Biosciences (KLDO) +21%.CEL-SCI (CVM) +21%.Novan (NOVN) +20%.Nikola (NKLA) +17%.Equifax (EFX) +17%.Losers: Evolus (EOLS) ...
Gainers: CEL-SCI (CVM) +20%, Renalytix RNLX +19%, Chemomab Therapeutics Ltd. (CMMB) +15%, Brooklyn ImmunoTherapeutics (BTX) +13%, Ocugen OCGN +13%.Losers: Evolus EOLS -18%, Precipio (PRPO) -9%, Shineco (TYHT) -8%, Adagene (ADAG)...
Precipio ([[PRPO]] -1.7%) launched a new At-The-Market financing arrangement wherein it can sell shares up to an aggregate of $20M.The company foresees that this will be its primary financing method going forward.This arrangement will be used in an ongoing manner to finance Precipio...
NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces a new “At-The-Market” (ATM) financing arrangement that improves its financing flexibility. As provided in the Company’s prospectu...
Precipio, Inc. (PRPO) Q4 2020 Earnings Conference Call Mar 31, 2021, 05:00 PM ET Company Participants Ilan Danieli - CEO Carl Iberger - CFO Conference Call Participants Presentation Operator Welcome to the Precipio Q4 2020 and Yearend Shareholder Update Call. All participants will be in a lis...
Precipio (PRPO): FY Gross profit of $0.5MRevenue of $1.9M (+171.4% Y/Y)Shares +4.48%.Press Release For further details see: Precipio reports FY results
NEW HAVEN, Conn., March 30, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO) , announced its audited results for 2020. The Company posted revenues of $6.1 million, an increase of $3.0 million from 2019, representing a 95% year-over-year in...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the quarter. It is important to not...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...